Remedies for allergic eye diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 4, 2004
app pub date -
Jan 5, 2004
filing date -
Jul 11, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
An agent for the treatment of allergic eye disease containing a 3-anilino-2-cycloalkenone derivative having the formula (I): 1 wherein R.sub.1 is an unsubstituted or substituted C.sub.1 to C.sub.8 alkyl group provided that an unsubstituted methyl group is excluded, a C.sub.3 to C.sub.7 cycloalkyl group, a C.sub.6 to C.sub.10 bicycloalkyl group or an indanyl group, etc., R.sub.2 is a C.sub.1 to C.sub.4 alkyl group, R.sub.3 is a hydrogen atom, a C.sub.1 to C.sub.5 alkyl group, a C.sub.3 to C.sub.7 cycloalkyl group, etc., R.sub.4 is a hydrogen atom, an unsubstituted or substituted C.sub.1 to C.sub.5 alkyl group, a halogen atom, etc., R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are independently a hydrogen atom, a C.sub.1 to C.sub.5 alkyl group, etc., X is --(CR.sub.11R.sub.12)n- or NR.sub.13--, wherein n is 0 to 2, R.sub.11, R.sub.12 and R.sub.13 are independently a hydrogen atom, a C.sub.1 to C.sub.5 alkyl group, etc.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully